Newsletters - MAR-APRIL 2006

Dear Reader,
We present to you the 75th volume of "Current Issues" this month. We hope you have found this newsletter from Sabinsa Corporation to be an useful source of information. We look forward to your feedback. Do write to us at This email address is being protected from spambots. You need JavaScript enabled to view it..
Thank you.
The Editorial Team

July 1997:Prof.Christian Barnard visits Sabinsa, NJ.

On July 2, Sabinsa was privileged by the visit of Prof. Christian Barnard, the surgeon who performed the first human heart transplant in 1967. Prof. Barnard concluded that Sabinsa's products are unique and of the highest quality and has agreed to endorse five of Sabinsa's products for the South African market.

 

July 1997: Sabinsa Corporation Opens Western U.S Facility

On August 5th, Sabinsa Corporation will open a new facility to better serve its western U.S. customers. The new facility will include raw material warehousing and shipping, as well as a sales and and customer service department.

 

February 1998: .... Sabinsa'sherbal ingredients: Sourced with care

Dr. Muhammed Majeed, President and C.E.O. of Sabinsa Corporation, examines Curcuma longa rhizomes at a plantation in India. These rhizomes will be processed in the state-of-theart manufacturing at Bangalore, India, to yield the standardized extract, Curcumin C3 Complex®

 

September 1998..... Patent on forskolin assigned to Sabinsa Corporation

Sabinsa Corporation was recently assigned a patent (U.S. Patent #5,804, 596, dated September 8, 1998) for the use of forskolin to promote lean body mass and treat mood disorders.

 

November-December 1999... Third U.S Patent granted for Bioperine®

Sabinsa Corporation has been granted its third patent by the U.S. Patent and Trademark Office on the use of its trademarked black pepper extract Bioperine®.

 

Nov.-Dec. 2000 ... New President of Sabinsa Corporation

We are proud to announce that Todd Norton, formerly Senior Executive Vice President of Sabinsa Corporation, has been promoted to President and Chief Operating Officer of Sabinsa Corporation.

 

July 2001.... ForsLean® Wins Best New Product Award

Sabinsa Corporation is the proud recipient of the NutrAward Best New Product of 2001 for ForsLean®.

 

Oct. 2002... New Super critical Extraction Facility

Sabinsa Corporation, announced the completion of its new supercritical carbon dioxide extraction facility.

 

December 2003: Sabinsa Corporation granted patent for Tetrahydrocurcuminoids

US Patent # 6,653,327 titled “Cross-regulin composition of tumericderived tetrahydrocurcuminoids for skin lightening and protection against UVB rays”.....

 

April-May 2004:Ellis Island Medal of Honor for Dr. Majeed

Join us in congratulating Dr.Muhammed Majeed who has been selected to receive the Ellis Island Medal of Honor for the year 2004.)

 

Oct.-Nov. 2004 Thomas Alva Edison Patent Award for Forslean®

Sabinsa Corporation received the Thomas Alva Edison Patent Award for the year 2004. This annual award instituted by the Research & Development Council of New Jersey.

 

May 2005: NSF Certification for Sabinsa's Products and Facilities

A plaque was presented to Todd Norton, President, Sabinsa Corporation, at the SupplySide Show in Baltimore, MD, acknowledging the certification.

 

Sept. Oct. 2005:

Sabinsa Corporation Receives the 2005 Thomas Alva Edison Patent Award... for its patent on method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine.

    VISIT US

  • Sabinsa Canada Inc.
    6800 Kitimat Road, Unit 28,
    Mississauga, ON L5N 5M1
    Canada

  • +1 905-286-6616
  • +1 437-988-1663
  • info@sabinsa.ca

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.